The relationship between CCR6 and its binding partners: Does the CCR6-CCL20 axis have to be extended?

Cytokine

Volumn 72, Issue 1, 2015, Pages 97-101

  Lee, Adrian Y S ^a,b   Phan, Thanh K ^c   Hulett, Mark D ^c   Körner, Heinrich ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

Author keywords

Beta defensins; CCL20; CCR6; Chemokines

Indexed keywords

BETA DEFENSIN; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR4; CUTANEOUS T CELL ATTRACTING CHEMOKINE; EOTAXIN 2; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; CCL20 PROTEIN, HUMAN; LIGAND;

ADAPTIVE IMMUNITY; BINDING AFFINITY; CELL ACTIVATION; ENZYME ACTIVATION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY T LYMPHOCYTE; REVIEW; UPREGULATION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DOWN REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MOUSE;

MUS;

ANIMALS; BETA-DEFENSINS; CHEMOKINE CCL20; DOWN-REGULATION; HUMANS; LIGANDS; MICE; MICE, KNOCKOUT; MODELS, MOLECULAR; RECEPTORS, CCR6; UP-REGULATION;

EID: 84922274206     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.11.029     Document Type: Review

References (65)

1. Zlotnik A., Yoshie O. The chemokine superfamily revisited. Immunity 2012, 36(5):705-716.
2. Hromas R., Gray P.W., Chantry D., Godiska R., Krathwohl M., Fife K., et al. Cloning and characterization of exodus, a novel β-chemokine. Blood 1997, 89(9):3315-3322.
3. Lee A.Y.S., Eri R., Lyons A.B., Grimm M.C., Korner H. CC chemokine ligand 20 and its cognate receptor CCR6 in mucosal T cell immunology and inflammatory bowel disease: odd couple or axis of evil?. Front Immunol 2013, 4:194.
4. Cook D.N., Prosser D.M., Forster R., Zhang J., Kuklin N.A., Abbondanzo S.J., et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 2000, 12(5):495-503.
5. Hieshima K., Imai T., Opdenakker G., Van Damme J., Kusuda J., Tei H., et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem 1997, 272(9):5846-5853.
6. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998, 188(2):373-386.
7. Reboldi A., Coisne C., Baumjohann D., Benvenuto F., Bottinelli D., Lira S., et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 2009, 10(5):514-523.
8. Schutyser E., Struyf S., Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 2003, 14(5):409-426.
9. Bowman E.P., Campbell J.J., Soler D., Dong Z., Manlongat N., Picarella D., et al. Developmental switches in chemokine response profiles during B cell differentiation and maturation. J Exp Med 2000, 191(8):1303-1318.
10. Greaves D.R., Wang W., Dairaghi D.J., Dieu M.C., Saint-Vis B., Franz-Bacon K., et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med 1997, 186(6):837-844.
11. Yang D., Howard O.M., Chen Q., Oppenheim J.J. Immature dendritic cells generated from monocytes in the presence of TGF-beta 1 express functional C-C chemokine receptor 6. J Immunol 1999, 163(4):1737-1741.
12. Baba M., Imai T., Nishimura M., Kakizaki M., Takagi S., Hieshima K., et al. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem 1997, 272(23):14893-14898.
13. Ma Q., Jones D., Borghesani P.R., Segal R.A., Nagasawa T., Kishimoto T., et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A 1998, 95(16):9448-9453.
14. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382(6592):635-638.
15. Lügering A., Floer M., Westphal S., Maaser C., Spahn T.W., Schmidt M.A., et al. Absence of CCR6 inhibits CD4+ regulatory T-cell development and M-cell formation inside Peyer's patches. Am J Pathol 2005, 166(6):1647-1654.
16. Fahy O.L., Townley S.L., Coates N.J., Clark-Lewis I., McColl S.R. Control of Salmonella dissemination in vivo by macrophage inflammatory protein (MIP)-3alpha/CCL20. Lab Invest 2004, 84(11):1501-1511.
17. Kallal L.E., Schaller M.A., Lindell D.M., Lira S.A., Lukacs N.W. CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC. Eur J Immunol 2010, 40(4):1042-1052.
18. Wen H., Hogaboam C.M., Lukacs N.W., Cook D.N., Lira S.A., Kunkel S.L. The chemokine receptor CCR6 is an important component of the innate immune response. Eur J Immunol 2007, 37(9):2487-2498.
19. Dohlman T.H., Chauhan S.K., Kodati S., Hua J., Chen Y., Omoto M., et al. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease. Invest Ophthalmol Vis Sci 2013, 54(6):4081-4091.
20. Yamazaki T., Yang X.O., Chung Y., Fukunaga A., Nurieva R., Pappu B., et al. CCR6 regulates the migration of inflammatory and regulatory T cells. J Immunol 2008, 181(12):8391-8401.
21. Villares R., Cadenas V., Lozano M., Almonacid L., Zaballos A., Martínez A C., et al. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues. Eur J Immunol 2009, 39(6):1671-1681.
22. Turner J.E., Paust H.J., Steinmetz O.M., Peters A., Riedel J.H., Erhardt A., et al. CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J Am Soc Nephrol 2010, 21(6):974-985.
23. reg cells correlates with enhanced local inflammation in cutaneous leishmaniasis in CCR6-deficient mice. PLoS ONE 2012, 7(9):e44499.
24. Liston A., Kohler R.E., Townley S., Haylock-Jacobs S., Comerford I., Caon A.C., et al. Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response. J Immunol 2009, 182(5):3121-3130.
25. Moriguchi K., Miyamoto K., Tanaka N., Yoshie O., Kusunoki S. The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis. J Neuroimmunol 2013, 257(1-2):53-58.
26. Comerford I., Bunting M., Fenix K., Haylock-Jacobs S., Litchfield W., Harata-Lee Y., et al. An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?. BioEssays 2010, 32(12):1067-1076.
27. Kleinewietfeld M., Hafler D.A. The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin Immunol 2013, 25(4):305-312.
28. Schutte B.C., Mitros J.P., Bartlett J.A., Walters J.D., Jia H.P., Welsh M.J., et al. Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci U S A 2002, 99(4):2129-2133.
29. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003, 3(9):710-720.
30. Pazgier M., Hoover D., Yang D., Lu W., Lubkowski J. Human β-defensins. Cell Mol Life Sci 2006, 63(11):1294-1313.
31. Boniotto M., Jordan W.J., Eskdale J., Tossi A., Antcheva N., Crovella S., et al. Human β-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells. Antimicrob Agents Chemother 2006, 50(4):1433-1441.
32. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999, 286(5439):525-528.
33. Rohrl J., Yang D., Oppenheim J.J., Hehlgans T. Identification and biological characterization of mouse beta-defensin 14, the orthologue of human beta-defensin 3. J Biol Chem 2008, 283(9):5414-5419.
34. Conejo-Garcia J.R., Benencia F., Courreges M.C., Kang E., Mohamed-Hadley A., Buckanovich R.J., et al. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat Med 2004, 10(9):950-958.
35. Caballero-Campo P., Buffone M.G., Benencia F., Conejo-Garcia J.R., Rinaudo P.F., Gerton G.L. A role for the chemokine receptor CCR6 in mammalian sperm motility and chemotaxis. J Cell Physiol 2014, 229(1):68-78.
36. Ghannam S., Dejou C., Pedretti N., Giot J.-P., Dorgham K., Boukhaddaoui H., et al. CCL20 and β-defensin-2 induce arrest of human Th17 cells on inflamed endothelium in vitro under flow conditions. J Immunol 2011, 186(3):1411-1420.
37. Vongsa R.A., Zimmerman N.P., Dwinell M.B. CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2-and CCL20-mediated restitution of colonic epithelial cells. J Biol Chem 2009, 284(15):10034-10045.
38. Hoover D.M., Boulegue C., Yang D., Oppenheim J.J., Tucker K., Lu W., et al. The structure of human macrophage inflammatory protein-3alpha/CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. J Biol Chem 2002, 277(40):37647-37654.
39. Soruri A., Grigat J., Forssmann U., Riggert J., Zwirner J. β-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. Eur J Immunol 2007, 37(9):2474-2486.
40. Morgera F., Pacor S., Creatti L., Antcheva N., Vaccari L., Tossi A. Effects on antigen-presenting cells of short-term interaction with the human host defence peptide beta-defensin 2. Biochem J 2011, 436(3):537-546.
41. Rohrl J., Yang D., Oppenheim J.J., Hehlgans T. Human β-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J Immunol 2010, 184(12):6688-6694.
42. De Paula V.S., Gomes N.S., Lima L.G., Miyamoto C.A., Monteiro R.Q., Almeida F.C., et al. Structural basis for the interaction of human β-defensin 6 and its putative chemokine receptor CCR2 and breast cancer microvesicles. J Mol Biol 2013, 425(22):4479-4495.
43. Feng Z., Dubyak G.R., Lederman M.M., Weinberg A. Cutting edge: human β defensin 3-a novel antagonist of the HIV-1 coreceptor CXCR4. J Immunol 2006, 177(2):782-786.
44. Funderburg N., Lederman M.M., Feng Z., Drage M.G., Jadlowsky J., Harding C.V., et al. Human-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc Natl Acad Sci U S A 2007, 104(47):18631-18635.
45. Wu Z., Hoover D.M., Yang D., Boulegue C., Santamaria F., Oppenheim J.J., et al. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci U S A 2003, 100(15):8880-8885.
46. Liao F., Alderson R., Su J., Ullrich S.J., Kreider B.L., Farber J.M. STRL22 is a receptor for the CC chemokine MIP-3α. Biochem Biophys Res Commun 1997, 236(1):212-217.
47. Liao F., Lee H.-H., Farber J.M. Cloning of STRL22, a new human gene encoding a G-protein-coupled receptor related to chemokine receptors and located on chromosome 6q27. Genomics 1997, 40(1):175-180.
48. Power C.A., Church D.J., Meyer A., Alouani S., Proudfoot A.E., Clark-Lewis I., et al. Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells. J Exp Med 1997, 186(6):825-835.
49. Yoshida R., Nagira M., Kitaura M., Imagawa N., Imai T., Yoshie O. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J Biol Chem 1998, 273(12):7118-7122.
50. Varona R., Zaballos A., Gutierrez J., Martin P., Roncal F., Albar J.P., et al. Molecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP-3alpha. FEBS Lett 1998, 440(1-2):188-194.
51. Kitaura M., Suzuki N., Imai T., Takagi S., Suzuki R., Nakajima T., et al. Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J Biol Chem 1999, 274(39):27975-27980.
52. Wang W., Soto H., Oldham E.R., Buchanan M.E., Homey B., Catron D., et al. Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem 2000, 275(29):22313-22323.
53. Hall D.A., Beresford I.J., Browning C., Giles H. Signalling by CXC-chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPgammaS binding induced by IL-8 and GROalpha. Br J Pharmacol 1999, 126(3):810-818.
54. Nakayama T., Watanabe Y., Oiso N., Higuchi T., Shigeta A., Mizuguchi N., et al. Eotaxin-3/CC chemokine ligand 26 is a functional ligand for CX3CR1. J Immunol 2010, 185(11):6472-6479.
55. Islam S.A., Ling M.F., Leung J., Shreffler W.G., Luster A.D. Identification of human CCR8 as a CCL18 receptor. J Exp Med 2013, 210(10):1889-1898.
56. Zissel G., Höhne K., Kilic A., Maier C., Ploenes T., Prasse A., et al. CCR6 is a receptor for CCL18 expressed on human lung fibroblasts from IPF lungs. Eur Respir J 2011, 38(Suppl 55).
57. Singh A., Kraaijeveld A., Legein B., Curaj A., Mccoll S., Heemskerk J., et al. P93CCL18 aggravates atherosclerosis by inducing CCR6-, not CCR3-, dependent T cell influx and polarization. Cardiovasc Res 2014, 103(suppl 1):S15-S16.
58. Luzina I., Atamas S. CCR6 is not necessary for functional effects of human CCL18 in a mouse model. Fibrogenesis Tissue Repair 2012, 5(1):1-3.
59. Liao F., Rabin R.L., Smith C.S., Sharma G., Nutman T.B., Farber J.M. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol 1999, 162(1):186-194.
60. Liao F., Shirakawa A.-K., Foley J.F., Rabin R.L., Farber J.M. Human B cells become highly responsive to macrophage-inflammatory protein-3α/CC chemokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding. J Immunol 2002, 168(10):4871-4880.
61. Ebert L.M., McColl S.R. Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4+ T lymphocytes. J Immunol 2002, 168(1):65-72.
62. Fitzhugh D.J., Naik S., Caughman S.W., Hwang S.T. Cutting edge: C-C chemokine receptor 6 is essential for arrest of a subset of memory T cells on activated dermal microvascular endothelial cells under physiologic flow conditions in vitro. J Immunol 2000, 165(12):6677-6681.
63. Meissner A., Zilles O., Varona R., Jozefowski K., Ritter U., Marquez G., et al. CC chemokine ligand 20 partially controls adhesion of naive B cells to activated endothelial cells under shear stress. Blood 2003, 102(8):2724-2727.
64. Hoover D.M., Chertov O., Lubkowski J. The structure of human beta-defensin-1: new insights into structural properties of beta-defensins. J Biol Chem 2001, 276(42):39021-39026.
65. Hoover D.M., Rajashankar K.R., Blumenthal R., Puri A., Oppenheim J.J., Chertov O., et al. The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J Biol Chem 2000, 275(42):32911-32918.